rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-9
|
pubmed:abstractText |
Nuchal translucency (NT) screening increases antenatal detection of Down syndrome (DS) compared to maternal age-based screening. We wanted to determine if a change in policy for prenatal diagnosis would result in fewer babies born with DS.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0960-7692
|
pubmed:author |
pubmed-author:AlmströmHH,
pubmed-author:BottingaRR,
pubmed-author:CederholmMM,
pubmed-author:ConnerPP,
pubmed-author:DannbergBB,
pubmed-author:GrunewaldCC,
pubmed-author:KublickasMM,
pubmed-author:MalcusPP,
pubmed-author:MarshDD,
pubmed-author:ReeE FEF,
pubmed-author:SaltvedtSS,
pubmed-author:ValentinLL
|
pubmed:copyrightInfo |
Copyright 2005 ISUOG
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
537-45
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2005
|
pubmed:articleTitle |
Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, South Stockholm General Hospital, Stockholm, Sweden. sissel.saltvedt@kids.ki.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|